178 related articles for article (PubMed ID: 12199723)
1. A postmarketing surveillance study of gabapentin as add-on therapy for 3,100 patients in England.
Wilton LV; Shakir S
Epilepsia; 2002 Sep; 43(9):983-92. PubMed ID: 12199723
[TBL] [Abstract][Full Text] [Related]
2. Adverse event monitoring in lamotrigine patients: a pharmacoepidemiologic study in the United Kingdom.
Wong IC; Mawer GE; Sander JW
Epilepsia; 2001 Feb; 42(2):237-44. PubMed ID: 11240596
[TBL] [Abstract][Full Text] [Related]
3. Monitoring the safety of pioglitazone : results of a prescription-event monitoring study of 12,772 patients in England.
Kasliwal R; Wilton LV; Shakir SA
Drug Saf; 2008; 31(10):839-50. PubMed ID: 18759508
[TBL] [Abstract][Full Text] [Related]
4. Gabapentin.
Morris GL
Epilepsia; 1999; 40 Suppl 5():S63-70. PubMed ID: 10530696
[TBL] [Abstract][Full Text] [Related]
5. Safety of zafirlukast: results of a postmarketing surveillance study on 7976 patients in England.
Twaites BR; Wilton LV; Shakir SA
Drug Saf; 2007; 30(5):419-29. PubMed ID: 17472420
[TBL] [Abstract][Full Text] [Related]
6. Safety profile of oxcarbazepine: results from a prescription-event monitoring study.
Buggy Y; Layton D; Fogg C; Shakir SA
Epilepsia; 2010 May; 51(5):818-29. PubMed ID: 20132298
[TBL] [Abstract][Full Text] [Related]
7. Safety and tolerability of gabapentin as adjunctive therapy in a large, multicenter study.
McLean MJ; Morrell MJ; Willmore LJ; Privitera MD; Faught RE; Holmes GL; Magnus-Miller L; Bernstein P; Rose-Legatt A
Epilepsia; 1999 Jul; 40(7):965-72. PubMed ID: 10403221
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of the safety of bupropion (Zyban) for smoking cessation from experience gained in general practice use in England in 2000.
Boshier A; Wilton LV; Shakir SA
Eur J Clin Pharmacol; 2003 Dec; 59(10):767-73. PubMed ID: 14615857
[TBL] [Abstract][Full Text] [Related]
9. Gabapentin versus lamotrigine monotherapy: a double-blind comparison in newly diagnosed epilepsy.
Brodie MJ; Chadwick DW; Anhut H; Otte A; Messmer SL; Maton S; Sauermann W; Murray G; Garofalo EA;
Epilepsia; 2002 Sep; 43(9):993-1000. PubMed ID: 12199724
[TBL] [Abstract][Full Text] [Related]
10. Safety of long-term lamotrigine in epilepsy.
Mackay FJ; Wilton LV; Pearce GL; Freemantle SN; Mann RD
Epilepsia; 1997 Aug; 38(8):881-6. PubMed ID: 9579888
[TBL] [Abstract][Full Text] [Related]
11. Gabapentin in childhood epilepsy: a prospective evaluation of efficacy and safety.
Korn-Merker E; Borusiak P; Boenigk HE
Epilepsy Res; 2000 Jan; 38(1):27-32. PubMed ID: 10604603
[TBL] [Abstract][Full Text] [Related]
12. Neurontin--1 year on. London October 1994.
Betts T
Seizure; 1995 Mar; 4(1):1-4. PubMed ID: 7788103
[No Abstract] [Full Text] [Related]
13. Safety profile of modafinil across a range of prescribing indications, including off-label use, in a primary care setting in England: results of a modified prescription-event monitoring study.
Davies M; Wilton L; Shakir S
Drug Saf; 2013 Apr; 36(4):237-46. PubMed ID: 23483377
[TBL] [Abstract][Full Text] [Related]
14. Safety profile of celecoxib as used in general practice in England: results of a prescription-event monitoring study.
Layton D; Wilton LV; Shakir SA
Eur J Clin Pharmacol; 2004 Sep; 60(7):489-501. PubMed ID: 15278327
[TBL] [Abstract][Full Text] [Related]
15. Long-term retention rates of lamotrigine, gabapentin, and topiramate in chronic epilepsy.
Lhatoo SD; Wong IC; Polizzi G; Sander JW
Epilepsia; 2000 Dec; 41(12):1592-6. PubMed ID: 11114218
[TBL] [Abstract][Full Text] [Related]
16. Gabapentin in refractory partial epilepsy--a trial in India.
Dixit SN; Jain S; Padma MV; Maheshwari MC
Acta Neurol Scand; 1996; 93(2-3):85-7. PubMed ID: 8741123
[TBL] [Abstract][Full Text] [Related]
17. Gabapentin.
McLean MJ
Epilepsia; 1995; 36 Suppl 2():S73-86. PubMed ID: 8784216
[TBL] [Abstract][Full Text] [Related]
18. Conversion to high dose gabapentin monotherapy in patients with medically refractory partial epilepsy.
Beydoun A; Fakhoury T; Nasreddine W; Abou-Khalil B
Epilepsia; 1998 Feb; 39(2):188-93. PubMed ID: 9577999
[TBL] [Abstract][Full Text] [Related]
19. Gabapentin as add-on therapy in children with refractory partial seizures: a 12-week, multicentre, double-blind, placebo-controlled study. Gabapentin Paediatric Study Group.
Appleton R; Fichtner K; LaMoreaux L; Alexander J; Halsall G; Murray G; Garofalo E
Epilepsia; 1999 Aug; 40(8):1147-54. PubMed ID: 10448830
[TBL] [Abstract][Full Text] [Related]
20. Safety profile of esomeprazole: results of a prescription-event monitoring study of 11 595 patients in England.
Davies M; Wilton LV; Shakir SA
Drug Saf; 2008; 31(4):313-23. PubMed ID: 18366242
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
